Prestige Consumer Healthcare
PBH
#3940
Rank
โ‚ฌ2.57 B
Marketcap
52,24ย โ‚ฌ
Share price
1.27%
Change (1 day)
-34.55%
Change (1 year)

EPS for Prestige Consumer Healthcare (PBH)

EPS in 2025 (TTM): 3,66ย โ‚ฌ

According to Prestige Consumer Healthcare's latest financial reports the company's current EPS (TTM) is 3,49ย โ‚ฌ. In 2024 the company made an earnings per share (EPS) of 3,69ย โ‚ฌ an increase over its 2023 EPS that were of -1,38ย โ‚ฌ.

EPS history for Prestige Consumer Healthcare from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)3,66ย โ‚ฌ-0.83%
20243,69ย โ‚ฌ-367.08%
2023-1,38ย โ‚ฌ-138.33%
20223,61ย โ‚ฌ11.7%
20213,23ย โ‚ฌ13.6%
20202,84ย โ‚ฌ-651.67%
2019-0,52ย โ‚ฌ-148.78%
20181,06ย โ‚ฌ-83.29%
20176,32ย โ‚ฌ437.23%
20161,18ย โ‚ฌ-34.13%
20151,79ย โ‚ฌ52.94%
20141,17ย โ‚ฌ-8.11%
20131,27ย โ‚ฌ
20110,75ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
GlaxoSmithKline
GSK
3,09ย โ‚ฌ-11.43%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
1,48ย โ‚ฌ-57.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Rite Aid
RAD
-25,44ย โ‚ฌ-829.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
8,97ย โ‚ฌ 157.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Taro Pharmaceutical
TARO
1,05ย โ‚ฌ-69.95%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Novartis
NVS
6,32ย โ‚ฌ 81.28%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Procter & Gamble
PG
6,04ย โ‚ฌ 73.15%๐Ÿ‡บ๐Ÿ‡ธ USA
CVS Health
CVS
0,34ย โ‚ฌ-90.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Clorox
CLX
5,51ย โ‚ฌ 57.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
6,92ย โ‚ฌ 98.45%๐Ÿ‡บ๐Ÿ‡ธ USA